Author(s)

Chris Mathew^1,2

¹Faculty of Science, St Mary’s Coptic Orthodox College, Coolaroo, Australia.
²Institute of Health and Sports (IHES), Victoria University, Melbourne, Australia.

Acute Kidney Injury (AKI) is a condition that causes nephrotoxicity in kidney tissues due to cisplatin-induced cancer treatments. Hence, it is proposed in this review that AVE0991 (a MAS-receptor Angiotensin II (1-7) agonist) may reduce cisplatin-induced acute kidney injury by promoting nitric oxide production.

Cisplatin, Acute Kidney Injury, AKI, Cisplatin-Induced Acute Kidney Injury, Nephrotoxicity, Renal Renin Angiotensin System, RAS, AVE0991, MAS-Receptor Angiotensin II (1-7) Agonist

Mathew, C. (2023) The Role for AVE0991 (MAS-Receptor Angiotensin II (1-7) Agonist) in Reducing Cisplatin-Induced Acute Kidney Injury on C57BL/6 Mice. Journal of Biosciences and Medicines, 11, 195-214. doi: 10.4236/jbm.2023.111019.